×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| Laurus Labs Limited | 14,244.70 | 929.40 | 14,150.50 | 1.71 | 28,119 | 141.0 |
| PIRAMAL PHARMA LIMITED | 12730.2 | 1188 | 12483.2 | 0.90 | 27715 | 528.0 |
| Gland Pharma Limited | 14425.46 | 2046.92 | 13840.52 | 12.42 | 25151 | 35.7 |
Laurus Labs Limited, with Security Code 540222, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,495.2 | 1,498.1 | 1,500.7 | 1,279.3 | 1,107.6 | 1,158.0 | 1,132.1 | 1,414.5 | 1,116.9 | 1,184.8 |
| Expenses | 1,077.1 | 1,072.1 | 1,115.6 | 1,026.9 | 979.8 | 977.5 | 961.8 | 1,143.4 | 955.5 | 1,003.0 |
| Operating Profit | 418.2 | 426.0 | 385.1 | 252.4 | 127.9 | 180.5 | 170.4 | 271.1 | 161.4 | 181.8 |
| OPM % | 27.97% | 28.44% | 25.66% | 19.73% | 11.55% | 15.59% | 15.05% | 19.17% | 14.45% | 15.35% |
| Other Income | 2.9 | 4.1 | 3.0 | 5.9 | 6.7 | 5.9 | 10.7 | 24.1 | 9.3 | 11.9 |
| Interest | 27.5 | 37.9 | 39.3 | 41.0 | 33.5 | 37.8 | 37.6 | 42.0 | 40.9 | 44.7 |
| Depreciation | 66.0 | 75.6 | 78.5 | 80.6 | 83.9 | 85.4 | 86.8 | 88.9 | 91.0 | 90.9 |
| Profit before tax | 327.6 | 316.7 | 270.3 | 136.8 | 17.2 | 63.2 | 56.7 | 164.3 | 38.8 | 58.1 |
| Tax % | 29.3% | 28.2% | 26.4% | 25.2% | 24.2% | 26.2% | 24.8% | 26.2% | 25.8% | 26.9% |
| Net Profit | 231.6 | 227.4 | 199.1 | 102.3 | 13.1 | 46.7 | 42.6 | 121.3 | 28.8 | 42.4 |
| EPS in Rs | 4.3 | 4.21 | 3.7 | 1.88 | 0.48 | 0.87 | 0.79 | 2.25 | 0.53 | 0.79 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,575.9 | 1,544.8 | 1,380.9 | 1,181.8 | 1,224.5 | 1,194.9 | 1,439.7 | 1,194.9 | 1,223.7 | 1,415.1 |
| Expenses | 1,127.4 | 1,141.8 | 1,097.3 | 1,016.7 | 1,038.8 | 1,015.3 | 1,198.5 | 1,023.7 | 1,045.4 | 1,129.9 |
| Operating Profit | 448.5 | 403.1 | 283.6 | 165.1 | 185.7 | 179.6 | 241.2 | 171.2 | 178.3 | 285.2 |
| OPM % | 28.5% | 26.1% | 20.5% | 14% | 15.2% | 15% | 16.8% | 14.3% | 14.6% | 20.2% |
| Other Income | 1.1 | 1.4 | 1.7 | 3.6 | 1.8 | 2.4 | 18.5 | 2.5 | 4.6 | 9.4 |
| Interest | 40.1 | 42.7 | 53.1 | 39.2 | 42.4 | 50.8 | 50.5 | 49.2 | 52.6 | 57.8 |
| Depreciation | 81.8 | 84.4 | 87.0 | 90.6 | 93.4 | 98.4 | 102.3 | 106.1 | 107.5 | 106.1 |
| Profit before tax | 327.7 | 277.3 | 145.2 | 39.0 | 51.7 | 32.8 | 107.0 | 18.5 | 22.8 | 130.7 |
| Tax % | 28.7% | 26.9% | 27.1% | 30% | 27% | 27.3% | 29.8% | 33.9% | 22.3% | 30.7% |
| Net Profit | 233.4 | 202.5 | 105.3 | 26.8 | 37.1 | 23.3 | 75.0 | 12.7 | 20.0 | 92.9 |
| EPS in Rs | 4 | 3 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 17% |
| 3 Years: | 0% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 19% |
| 3 Years: | -38% |
| TTM: | 22% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 43% |
| 3 Years: | -1% |
| 1 Year: | 31% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 17% |
| 3 Years: | 2% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 11% |
| 3 Years: | -45% |
| TTM: | 6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 43% |
| 3 Years: | -1% |
| 1 Year: | 31% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|